Patents - stay tuned to the technology

Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


18th week of 2010 patent applcation highlights part 65
Patent application numberTitlePublished
20100113824Dicarboxylic Acid Production with Self-Fuel Oxidative Destruction - The invention provides improved energy content in and shaft power recovery from off-gas from xylene oxidation reactions while at the same time minimizing wastewater treatment cost. More shaft power is produced using off-gas than is required to drive the main air compressor, even with preferred, relatively low oxidation temperatures. Simultaneously, an amount of wastewater greater than byproduct water from oxidation of xylene is kept in vapor form and treated along with off-gas pollutants in a self-sustaining (self-fueling) gas-phase thermal oxidative destruction unit. Optionally, off-gas is combined from multiple xylene oxidation reactors, comprising primary and/or secondary oxidation reactors and forming TPA and/or IPA. Optionally, air compressor condensate and caustic scrubber blowdown are used in a TPA process or as utility water, effectively eliminating normal flow of liquid wastewater effluent from a TPA plant. Optionally, PET off-gas containing the water of PET formation is treated in a shared thermal oxidative destruction unit, effectively eliminating normal flow of liquid wastewater effluent from a combined pX-to-TPA-to-PET plant.2010-05-06
20100113825Dicarboxylic Acid Production with Direct Fired Off-Gas Heating - The invention provides improved energy content in and shaft power recovery from off-gas from xylene oxidation reactions while at the same time minimizing wastewater treatment cost. More shaft power is produced using off-gas than is required to drive the main air compressor, even with preferred, relatively low oxidation temperatures. Simultaneously, an amount of wastewater greater than byproduct water from oxidation of xylene is kept in vapor form and treated along with off-gas pollutants in a self-sustaining (self-fueling) gas-phase thermal oxidative destruction unit. Optionally, off-gas is combined from multiple xylene oxidation reactors, comprising primary and/or secondary oxidation reactors and forming TPA and/or IPA. Optionally, air compressor condensate and caustic scrubber blowdown are used in a TPA process or as utility water, effectively eliminating normal flow of liquid wastewater effluent from a TPA plant. Optionally, PET off-gas containing the water of PET formation is treated in a shared thermal oxidative destruction unit, effectively eliminating normal flow of liquid wastewater effluent from a combined pX-to-TPA-to-PET plant.2010-05-06
20100113826Dicarboxylic Acid Production with Enhanced Energy Recovery - The invention provides improved energy content in and shaft power recovery from off-gas from xylene oxidation reactions while at the same time minimizing wastewater treatment cost. More shaft power is produced using off-gas than is required to drive the main air compressor, even with preferred, relatively low oxidation temperatures. Simultaneously, an amount of wastewater greater than byproduct water from oxidation of xylene is kept in vapor form and treated along with off-gas pollutants in a self-sustaining (self-fueling) gas-phase thermal oxidative destruction unit. Optionally, off-gas is combined from multiple xylene oxidation reactors, comprising primary and/or secondary oxidation reactors and forming TPA and/or IPA. Optionally, air compressor condensate and caustic scrubber blowdown are used in a TPA process or as utility water, effectively eliminating normal flow of liquid wastewater effluent from a TPA plant. Optionally, PET off-gas containing the water of PET formation is treated in a shared thermal oxidative destruction unit, effectively eliminating normal flow of liquid wastewater effluent from a combined pX-to-TPA-to-PET plant.2010-05-06
20100113827Removing iodobenzene compounds from acetic acid - A method for removing iodobenzene compounds from an acetic acid is disclosed. The method comprises contacting an acetic acid with palladium supported on macroreticular ion-exchange resins. A process for producing acetic acid is also disclosed. The process comprises carbonylating methanol in the presence of a carbonylation catalyst and a triphenylphosphine oxide stabilizer to produce acetic acid which contains iodobenzene compounds and removing the iodobenzene compounds by contacting the acetic acid product with palladium.2010-05-06
20100113828MULTI-ARMED CATECHOL COMPOUND BLENDS - The invention describes families of compounds that utilize multihydroxyl phenyl groups to provide adhesive properties. Selection of the multihydroxy phenyl group along with linkers or linking groups and the linkages between the linkers or linking groups with polyalkylene oxides, provides materials that can be engineered to afford controllable curing time, biodegradation and/or swelling.2010-05-06
20100113829FORMULATIONS OF SUBEROYLANILIDE HYDROXAMIC ACID AND METHODS FOR PRODUCING SAME - The present invention provides a pharmaceutical composition or crystalline composition with a specific dissolution profile, which comprises suberoylanilide hydroxamic acid or a pharmaceutically acceptable salt or hydrate thereof as an active ingredient. The present invention provides a process of producing said crystalline composition or pharmaceutical composition. The present invention also provides compositions with a specific particle size distribution.2010-05-06
20100113830METHOD FOR PRODUCING ARYLHYDROXYLAMINE - Problem To provide a method for producing an arylhydroxylamine compound efficiently and safely under mild conditions.2010-05-06
20100113831Highly Pure Crystalline Benzphetamine Hydrochloride and Processes for Preparing - A highly pure crystalline form of benzphetamine hydrochloride and methods for the purification and crystallization of benzphetamine hydrochloride in high yield are disclosed.2010-05-06
20100113832PALLADIUM CATALYSTS - The invention relates to a particulate substance comprising a particulate porous support coupled to a palladium species. The palladium species may comprise palladium nanoclusters. The particulate substance may be used as a catalyst for conducting a carbon-carbon coupling reaction or a reduction.2010-05-06
20100113833Novel Catalysts and Process for Dehydrating Glycerol - A process for preparing acrolein from glycerol using an acidic solid-state catalyst which comprises tungsten compounds and further promoters.2010-05-06
20100113834Method for Producing 3,3,3-Trifluoropropionyl Chloride - There is provided a process for producing 3,3,3-trifluoropropionyl chloride, which is characterized in that 3,3,3-trifluoropropionaldehyde is chlorinated by a chlorinating agent selected from the group consisting of chlorine (Cl2010-05-06
20100113835Method for producing optically active aziridine compounds and amine compounds as well as complexes and their intermediates used in this method - This invention provides a method for producing an optically active aziridine compound or amine compound, which uses as a catalyst a Ru(salen)(CO) complex represented by the following formula (I) or its enantiomer having a high stability, in a high turnover number (TON) and a high enantioselectivity. In the formula (I), Ar is represented by the following formula (VI) or (VII), wherein in the formula (VI), Xs are independently a halogen or a halogenated alkyl group and R2010-05-06
20100113836METHOD FOR PRODUCING HYDROXY PIVALIN ALDEHYDE AND NEOPENTYL GLYCOL - The preparation of hydroxypivalaldehyde is effected by aldolizing isobutyraldehyde with formaldehyde and subsequently working up the resulting reaction effluent by distillation, wherein the reaction effluent is fed to a distillation column which is operated at a top pressure in the range from 0.5 to 1.5 bar and in which a two-stage condensation is provided in the top region, in which the vapors are first conducted into a partial condenser operated at a temperature in the range from 50 to 80° C., whose condensate is recycled at least partly into the distillation column, and in which the vapors uncondensed in the partial condenser are fed to a downstream condenser operated at a temperature in the range from −40 to +30° C., whose condensate is at least partly discharged.2010-05-06
20100113837Production of pheromones and fragrances from substituted and unsubstituted 1-alken-3yl alkylates - Compounds of the formula (I)2010-05-06
20100113838PROCESS FOR PRODUCING ACROLEIN - There is provided a process for producing acrolein, which makes it possible to obtain acrolein in high yield by dehydration of glycerin. Glycerin is allowed to coexist with a catalyst containing a rare earth metal salt crystal of phosphoric acid, thereby dehydrating the glycerin, wherein the crystal is obtained by calcining a solid which is formed by allowing a liquid containing water and a hydroxide of the rare earth metal and/or a dehydration condensate of the hydroxide to contain phosphate ions.2010-05-06
20100113839METHOD FOR LITHIUM EXCHANGE REACTIONS - The present invention relates to a process for lithium exchange reactions comprising mixing at least two fluids in a microreactor having at least two injection points.2010-05-06
20100113840Plants with altered carbon allocation - The present invention relates to compositions and methods for altering carbon allocation in plants. In particular, the present invention provides for the use of plants with altered carbon allocation in generating biofuels by modifying the carbon allocation in plants such that carbon is preferentially allocated into starch and soluble sugars in plant leaves in lieu of typical carbon sinks, thereby allowing the carbon to be more readily fermentable for use as biofuels.2010-05-06
20100113841PROCESS FOR PRODUCING HYDROGENOLYSIS PRODUCTS OF POLYHYDRIC ALCOHOLS - The present invention relates to a process for producing hydrogenolysis products of polyhydric alcohols with a good selectivity and a high yield, as well as hydrogenolysis catalysts used in the production process. The present invention provides (1) a process for producing a hydrogenolysis product of a polyhydric alcohol which includes the step of reacting the polyhydric alcohol with hydrogen in the presence of a catalyst containing a copper component, wherein the catalyst is a catalyst (A) containing the copper component, an iron component and an aluminum component, or a catalyst (B) containing the copper component and a silicon component; and (2) a hydrogenolysis catalyst for polyhydric alcohols which includes a copper component, an iron component and an aluminum component, and (3) a hydrogenolysis catalyst for polyhydric alcohols which includes a copper component and a silicon component.2010-05-06
20100113842METHOD FOR PRODUCING ALCOHOL BY HYDROGENATING LACTONE AND CARBOXYLIC ACID ESTER IN LIQUID PHASE - Disclosed is a method for producing an alcohol from a lactone or a carboxylic acid ester, which enables to produce an alcohol from a lactone or a carboxylic acid ester under relatively mild conditions with high yield and high catalytic efficiency. This method also enables to produce an optically active alcohol from an optically active lactone or an optically active carboxylic acid ester. Specifically disclosed is a method for producing an alcohol by hydrogen reducing a lactone or a carboxylic acid ester in the presence of a catalyst containing ruthenium and a phosphine compound represented by the following general formula (1):2010-05-06
20100113843PROCESS OF PRODUCING MONOHYDRIC ALCOHOLS FROM MONOCARBOXYLIC ACIDS OR DERIVATIVES THEREOF - Disclosed herein is a method for producing monohydric alcohols from monocarboxylic acids or derivatives thereof using a catalyst comprising ruthenium (Ru) and tin (Sn) using zinc oxide (ZnO) as both a catalyst support and an active promoter; a catalyst prepared by adding an inorganic binder such as silica, alumina or titania in a limited range to the catalyst comprising the above components in order to impart a shaping ability to the catalyst; or, a modified catalyst reformed by adding at least one reducing component selected from the group consisting of Co, Ni, Cu, Ag, Rh, Pd, Re, Ir, and Pt to the catalyst in order to improve the reducing ability of the catalyst. By using such catalysts, the method according to the present invention is advantageous in that the monohydric alcohols can be prepared in high yield regardless of whether the monocarboxylic acids contain water or not, the monohydric alcohols can be economically prepared because the catalysts can be operated under mild reaction conditions and also exhibits high selectivity and productivity compared to conventional catalysts, and the catalysts have excellent long-term reaction stability so as to be advantageous for industrial applications.2010-05-06
201001138441,4-HYDROGENATION OF SORBOL WITH RU COMPLEXES - The present invention relates to the use of Ru complexes, having a pentamethyl-cyclopentadienyl and a cyclooctadine as ligands, together with some acidic additives for improving the selectivity in the 1,4-hydrogenation of sorbol into the corresponding Z-alkene as major product.2010-05-06
20100113845ACCELERATED HYDRATE FORMATION AND DISSOCIATION - The invention relates to using gas hydrate to separate specific gases from a gas mixture. In particular, compound hydrate is formed from a mixed gas feedstock to concentrate one or more desired gas species in the hydrate phase and the remainder in the gas phase. The hydrate is then separated from the gas phase and dissociated to produce a gas stream concentrated in the desired species. Additives that accelerate the growth of hydrate and a defoaming agent are added to change the rate of reaction and eliminate hard to break foam produced by the catalyst to enhance total throughput through the process. The addition of some materials can result in changes in the density of the hydrate product, which can be useful for optimizing the separation of hydrate from unreacted liquid and/or rejected gas.2010-05-06
20100113846CONVERSION OF PRENYL DERIVATIVES TO ISOPRENE - The present invention provides methods for producing derivatives from cultured cells. In addition, the present invention provides methods for conversion of prenyl deerivatives, obtained from biological or petrochemical sources, to isoprene by employing chemical or biological catalysts. The present invention also provides compositions that include the cultured cells or isoprene or prenyl derivatives produced there from.2010-05-06
20100113847Olefin Oligomerization And Biodegradable Compositions Therefrom - A hydrocarbon fluid composition that comprises species of at least two different carbon numbers, an aerobic biodegradability of greater than 40% at 28 days, a cetane number of less than 60, and a certain boiling point range; and a process for making the hydrocarbon fluid composition.2010-05-06
20100113848PROCESS FOR THE CONVERSION OF RENEWABLE OILS TO LIQUID TRANSPORTATION FUELS - A method of producing a hydrocarbon product by hydrotreating a feedstock comprising triacylglyceride (TAG) in the presence of a nonsulfided hydrotreating catalyst to produce a first product comprising hydrocarbons. A method of producing a transportation fuel by selecting an undoped feedstock comprising virgin TAG, used TAG, or a combination thereof; hydrotreating the undoped feedstock in the presence of an unsulfided hydrotreating catalyst to produce a first product; and subjecting the first product to at least one process selected from aromatization, cyclization, and isomerization; to produce a second hydrocarbon product selected from gasoline, kerosene, jet fuel, and diesel fuels.2010-05-06
20100113849BIOMASS CONVERSION PROCESS - A process is disclosed including: contacting solid biomass with a first catalyst stream in a first reaction zone operated at a temperature T2010-05-06
20100113850Stable Shape-Selective Catalyst for Aromatic Alkylation and Methods of Using and Preparing - A catalyst and method of forming a catalyst for use in aromatic alkylation involves treating a zeolite, which may be a ZSM-5 zeolite, with a phosphorus-containing compound. The phosphorus-treated zeolite is combined with a binder material. The bound phosphorus-treated zeolite is treated with an aqueous solution of a hydrogenating metal compound by contacting the bound phosphorus-treated zeolite with the aqueous solution and separating the aqueous solution from the bound phosphorus-treated zeolite to form a hydrogenating-metal-containing zeolite catalyst. The catalyst may be used in preparing an alkyl aromatic product by contacting a hydrogenating-metal-containing zeolite catalyst with an aromatic alkylation feed of an aromatic compound and an alkylating agent under reaction conditions suitable for aromatic alkylation.2010-05-06
20100113851System and Method of Deactivating and Quenching an Oligomerization Catalyst - A method of deactivate a catalyst system is described. The method may include contacting a reactor effluent comprising a catalyst system, an oligomerized olefin, and diluent with a kill agent to at least partially deactivate the catalyst system, separating the reactor effluent into one or more first streams comprising oligomerized olefin and diluent, the one or more first streams being substantially devoid of the at least partially deactivated catalyst, and a second stream comprising the deactivated catalyst; and contacting the second stream with a quench agent.2010-05-06
20100113852OLIGOMERIZATION CATALYST SYSTEM AND PROCESS FOR OLIGOMERIZING OLEFINS - Among other things, this disclosure provides an olefin oligomerization system and process, the system comprising: a) a transition metal compound; b) a pyrrole compound having independently-selected C2010-05-06
20100113853Method of Purifying 2,7-Dimethylnaphthalene - [Object] To provide a method of making high-purity 2,7-dimethylnaphthalene from a dimethylnaphthalene isomer mixture at high yield by a simple industrial process with low production costs.2010-05-06
20100113854AGGLOMERATED ZEOLITIC ADSORBENTS, THEIR METHOD OF PREPARATION AND THEIR USES - The present invention relates to agglomerated zeolitic adsorbents based on zeolite X with an Si/Al ratio such that 1.152010-05-06
20100113855Low-Foaming Gas Processing Compositions And Uses Thereof - The invention relates to low-foaming gas processing compositions comprising (a) a silicone antifoam component comprising a base silicone fluid and a particulate metal oxide; (b) an emulsifying component in an amount suitable for the at least substantial emulsification of the silicone antifoam component in water; (c) a polypropylene glycol component at least partially soluble, emulsifiable, and/or dispersible in water; (d) a water-soluble or water-dispersible gas processing agent; and (e) water. The invention also relates to methods for processing a gas by treating the gas with these foam suppressing compositions.2010-05-06
20100113856APPARATUS AND METHOD FOR REMEDIATION OF AQUEOUS SOLUTIONS - A swellable sol-gel composition includes a plurality of interconnected organosilica nanoparticles. When dried, the swellable sol-gel composition is capable of swelling to at least twice its dried volume when placed in contact with a non-polar or organic sorbate.2010-05-06
20100113857FIBERS FOR DECONTAMINATION OF CHEMICAL AND BIOLOGICAL AGENTS - A nano-sized or micro-sized fiber comprising particles capable of at least partially detoxifying a toxic agent.2010-05-06
20100113858METHOD OF RADIUM STABILIZING IN SOLID EFFLUENT OR EFFLUENT CONTAINING SUBSTANCES IN SUSPENSION - Method of stabilizing radium present in radium-containing effluent, in which the effluent and a metal chloride are mixed, then the previously obtained mixture is reacted with a sulfate ion to obtain effluent containing stabilized radium. The chloride can be a barium, strontium or lead chloride. The sulfate ion can be supplied by the addition of sulfuric acid, sulfuric anhydride, soluable sulfate or soluble sulfate salt. The method applies in particular to the treatment of solid radium-containing effluents or effluents containing substances in suspension coming from chemistry or metallurgy of zirconium or treatment of uranium-containing minerals.2010-05-06
20100113859METHOD OF ASBESTOS DETOXIFICATION AND AQUEOUS SOLUTION FOR ASBESTOS DETOXIFICATION - A method of asbestos detoxification in which an asbestos-containing waste material in any form is made harmless while preventing asbestos particles or dust from flying or scattering. The asbestos content can be easily reduced in a short time to 0.1 wt. % or lower, which is prescribed by the Ministry of Health, Labor, and Welfare. The waste can be perfectly made harmless. Also provided is an aqueous solution for asbestos detoxification which is for use in the method. The method of asbestos detoxification comprises: bringing an asbestos-containing waste material into contact with an aqueous treating solution containing at least one fluoride ion source selected from the group consisting of the fluorides of alkali metals, alkaline earth metals, and ammonia and hydrofluoric acid and further containing at least one mineral acid selected from the group consisting of hydrochloric acid, sulfuric acid, and nitric acid so that the aqueous treating solution has a pH of 1 or lower; and allowing the resultant mixture to stand or stirring it while adding the mineral acid so as to keep the pH of the aqueous treating solution at 1 or lower. Thus, the asbestos in the asbestos-containing waste material is made harmless.2010-05-06
20100113860TEMPORARY TATTOO COVER AND RELATED METHOD - A cover for protecting a temporary mark on a person's skin includes a transparent layer and an associated opaque layer, wherein the opaque layer features an opening through which the temporary mark may be located as the cover is applied. An adhesive is superimposed upon the transparent layer in order to releasably affix the cover to the temporary mark, and also to permit maintaining the cover on a backing material during transportation or storage. During use, the mark is sighted through the transparent layer and the opening in the opaque layer, and applied to the patient's skin. The opaque layer is then removed from the transparent layer, which remains in place over the temporary mark, permitting the person to bathe or otherwise participate unhindered in his or her life's routines without smudging, wearing or removing the mark.2010-05-06
20100113861METALLIC NANOPARTICLES WITH COATED SHELLS AND APPLICATIONS OF SAME - A process or method for treating cancer. In one embodiment, the method includes the steps of providing a plurality of metallic nanoparticles, wherein each of the plurality of metallic nanoparticles has a core formed with a first metallic material, and a shell formed with a non-metallic material containing carbon, and wherein the shell is formed to enclose the metallic core completely, introducing said metallic nanoparticles into a mammal such that said metallic nanoparticles selectively target at least one type of cancerous cell, and subsequently applying at least one radio frequency of electromagnetic waves to said mammal for a period of time effective to induce skin currents in the cores of the first metallic material of said metallic nanoparticles to cause heat generated locally around targeted at least one type of cancerous cell to kill said cancerous cell.2010-05-06
20100113862TREATMENT OF AMELIORATION OF ARTHRITIC JOINT PAIN - An apparatus for treatment of pain includes a coil formed by a generally flat elliptical base member wrapped by wire in two separated grooves spaced axially along the outer surface and a portable battery powered generator unit for generating a current such that the electromagnetic field has a required magnitude of magnetic flux density in the range 1×1042010-05-06
20100113863Methods and Systems for Using Transcranial Magnetic Stimulation to Enhance Cognitive Performance - Methods and systems are provided for using transcranial magnetic stimulation (TMS) to enhance cognitive performance of at least one subject. At least one neural circuit is located in the brain of the subject, which is activated when the subject performs a predetermined task. Functional magnetic resonance imaging maps may be used to scan and generate maps of the interested neural circuits so as to locate proper neural circuits responsible for a predetermined task. An electromagnetic coil is positioned over a region on the scalp of the subject corresponding to the at least one neural circuit in the brain of the subject. A transcranial magnetic stimulation is delivered from the coil to the region on the scalp of the subject to induce current to flow in the brain that causes neuronal depolarization in the brain and effectuates a change in the performance of the predetermined task by the subject.2010-05-06
20100113864Incubator - In an incubator according to the present invention, a single incubator can be used in any state of four types of devices and thus obviates the need for having many types of devices. A canopy is lowered and raised. In addition to that, a left and right treatment door and a foot end treatment door can be located at their highest positions, lowest positions, and intermediate positions. Also, an infrared heater can be lowered and raised independently of the canopy. This makes it possible to switch the incubator among: a state of an open type incubator; a state of a closed type incubator in which the infrared heater is at its highest position such that the infrared heater can heat the canopy and others; a state of a closed type incubator in which the infrared heater is at its lowest position and this incubator is easily conveyable; and a state of a resuscitation treatment device.2010-05-06
20100113865SYSTEM AND METHOD FOR RELAXATION2010-05-06
20100113866ATRAUMATIC MEDICAL DEVICE ANCHORING AND DELIVERY SYSTEM - Systems and methods are delineated for treating urinary incontinence (UI). And more generally, systems and methods are delineated for providing medical treatment, wherein such systems and methods include means for attaching a structure to a patient and removing the structure without damage to the structure or the patient. An exemplary system for providing medical treatment comprises a structure having a first end and a second end for attachment to a patient. A first fastener is coupled to the first end and includes at least one retractable barb for attachment to the patient. A second fastener is coupled to the second end and includes at least one retractable barb for attachment to the patient. Removable fasteners including retractable barbs or equivalents thereof permit removal of the structure from the patient without damage to the structure as well as limiting trauma to the patient.2010-05-06
20100113867METHODS FOR MAINTAINING GENETIC STABILITY OF INBRED ANIMAL STRAINS - The present invention provides novel methods of maintaining genetic stability of non-human animal inbred strains. In the methods, pedigree-tracked cryopreserved embryos or gametes or pre-gametes derived from a foundation colony are produced and used to re-establish the foundation colony at appropriate intervals.2010-05-06
20100113869SYSTEMS AND METHODS FOR TREATING ANTERIOR PELVIC ORGAN PROLAPSE - A system for treating anterior pelvic organ prolapse according to one aspect of the present invention comprises a cape for supporting an anterior organ (such as a bladder) that has prolapsed into a vagina, a plurality of support arms coupled to the cape, and a plurality of fasteners for attaching the support arms to a portion of the pelvic wall. Each one of the plurality of fasteners is coupled to a respective one of the plurality of support arms. The system further includes a tension adjustment system. Among other things, the present invention provides an integrated, pre-fabricated solution to anterior pelvic organ prolapse. All components of the system can thus be quickly deployed, without the need to build the repair system piecemeal. Among other things, this results in quicker surgeries, less risk to the patient from anesthesia, and less risk of failure of the repair due to the improper assembly of the repair system. Additionally, the present invention provides a completely transvaginal solution to treating anterior pelvic organ prolapse, is easier for less experienced surgeons to perform, and poses far less risk of injury or death to the patient.2010-05-06
20100113870SYSTEMS AND METHODS FOR TREATING POSTERIOR PELVIC ORGAN PROLAPSE - A system for treating posterior pelvic organ prolapse according to one aspect of the present invention comprises a cape for supporting a posterior organ (such as a rectum and/or bowel) that has prolapsed into a vagina, a plurality of support arms coupled to the cape, and a plurality of fasteners for attaching the support arms to a portion of the pelvic sidewall. Each one of the plurality of fasteners is coupled to a respective one of the plurality of support arms. The system may further include a tension adjustment system. Among other things, the present invention provides an integrated, pre-fabricated solution to treating posterior pelvic organ prolapse. All components of the system can thus be quickly deployed, without the need to build the repair system piecemeal. Additionally, the present invention provides a completely transvaginal solution to posterior pelvic organ prolapse, is easier for less experienced surgeons to perform, and poses far less risk of injury or death to the patient.2010-05-06
20100113871ANTIMICROBIAL COATING - The invention relates to a formulation for preparing an antimicrobial lubricious hydrophilic coating, which formulation comprises a hydrophilic polymer; an initiator; particles comprising metallic silver (i.e. Ag°); and a carrier liquid. The invention further relates to an article comprising a hydrophilic coating on a surface wherein the coating comprises a cured hydrophilic polymer and particles comprising metallic silver.2010-05-06
20100113872MEDICAL APPARATUS AND PROCEDURE OF INSTALLING MEDICAL APPARATUS IN PATIENT - A medical apparatus includes a medical instrument that is introduced into a body cavity and has a driven posture control portion; a fixing portion for fixing the medical instrument to a body wall inside a body cavity; a movable portion that is interposed between the medical instrument and the fixing portion and movably connects the medical instrument to the fixing portion; and an extracorporeal device that is installed outside the body and has a posture control portion that moves the medical instrument relative to the fixing portion.2010-05-06
20100113873SUTURING DEVICE AND SUTURING SYSTEM - A suturing device for suturing tissues by using a suturing unit having an anchor mounted to an end portion of a suturing thread is provided, the suturing device including: a pair of first and second jaws which are opened or closed so as to grip the tissue; a hollow needle tube which receives the anchor in an inner cavity thereof; and a pusher which is inserted through the needle tube in a freely advancing and retracting manner and is capable of pushing the anchor received in the needle tube toward a distal end of the needle tube, in which the needle tube is disposed so as to intersect the first jaw and to allow the distal end thereof to face the second jaw, and in which, when the tissue is gripped by the first and second jaws, the needle tube is inserted into the tissue.2010-05-06
20100113874TELEOPERATED ENDOSCOPIC CAPSULE - Teleoperated endoscopic capsule for diagnostic and/or therapeutic purposes inside a cavity in a human body, comprising a body (2010-05-06
20100113875ENDOSCOPE AND MOVEMENT CONTROL SYSTEM OF THE SAME - Disclosed are an endoscope and a system for controlling movement of the same. The system includes an elastic spring having a predetermined length, a camera mounted on an end of the elastic spring, a plurality of link bodies shaped to fit around the elastic spring and disposed to have a predetermined interval therebetween, a plurality of wires connected with the plurality of link bodies for allowing each of the plurality of link bodies to be connected with each other along a longitudinal direction of the elastic spring, a plurality of driving modules connected with an end of each of the plurality of wires for tightening or loosening each of the plurality of wires, and a control module electrically connected with the plurality of driving modules and the camera for driving the plurality of the driving modules and receiving visual information from the camera.2010-05-06
20100113876ENDOSCOPE APPARATUS AND ENDOSCOPE-IMAGE RECORDING METHOD - An endoscope apparatus including an insertion portion for insertion into a body cavity; an image-acquisition unit disposed at a tip thereof that acquires an image of the inside of the body cavity; an insertion-length measuring unit disposed at a base end of the insertion portion that measures an insertion length of the insertion portion inside the body cavity; a storage unit that stores the image acquired by the image-acquisition unit in association with the insertion length measured by the insertion-length measuring unit; a following decision unit that determines whether insertion movement at the tip follows insertion movement at the base end; and a correcting unit that corrects the insertion length of the insertion portion associated with the acquired image to cancel a change in the insertion length measured in a non-following period on the basis of the result of that determination.2010-05-06
20100113877MEDICAL APPARATUS - A medical apparatus having a medical device that is utilized to perform a predetermined medical action, includes an energy supply source including an attachment/detachment portion to/from which the medical device is attached/detached, and supplies energy when the medical device is utilized to perform the predetermined medical action, an energy output adjustment unit which adjusts the energy supplied from the energy supply source to medical action energy suitable for performing the predetermined medical action by using the medical device when the medical device is connected to the attachment/detachment portion, and an energy supply detecting mechanism for detecting a state that the energy supply source has supplied the medical action energy. When the determination mechanism detects a state that the energy supply source has supplied the medical action energy, the energy output from the energy supply source is prevented from being supplied to the medical device.2010-05-06
20100113878Endoscopic multi-purpose treatment hood and endoscope - On the periphery of a silicon tube 2010-05-06
20100113879ENDOSCOPE AND FLEXIBLE TUBE THEREOF - A flexible tube making up most of the length, in the longitudinal direction, of an insertion section of an endoscope from a connection section of the insertion section to a manipulation section. The flexible tube including a helical tube formed with a strip shaped member wound in a helical shape and a mesh tube at the outer periphery of the helical tube, the mesh tube formed in a ring shape from braided fine wires. A thermoplastic resin is formed in a patterned shape at the outer periphery of the mesh tube, and an outer skin, formed at the outer periphery of the mesh tube at which is formed the thermoplastic resin, is made from a material that has a smaller thermal deformation than the thermoplastic resin. The flexible tube of the endoscope is not readily thermally deformed and is not readily imparted with a permanent or semi-permanent curvature when autoclave processing.2010-05-06
20100113880Gastrostomy-jejunostomy tube apparatus and method for endoscopically placing same within a patient - A percutaneous endoscopic gastrostomy-jejunostomy (G-J) tube apparatus has a percutaneous endoscopic gastrostomy-jejunostomy (PEG-J) tube unit and a jejunostomy (J-tube). The PEG-J tube unit includes two interconnected tubes extending in a side-by-side orientation with respect to each other and a posterior bumper encompassing both of the interconnected tubes adjacent a first end portion thereof. Each one of the interconnected tubes includes a passage extending therethrough between opposing end faces thereof. A first one of the interconnected tubes is configured for functioning as a gastrostomy tube (G-tube) and a second one of the interconnected tubes is configured for functioning as a jejunostomy tube (J-tube) introducer. The J-tube is slideably inserted into a passage of the J-tube introducer. The J-tube includes a plug portion integral therewith and disposed within the passage of the J-tube introducer for providing a fluid-resistant seal between the J-tube and the J-tube introducer.2010-05-06
20100113881Surgical retractor extensions - A method of preventing tissue creep using a surgical retractor apparatus having one or more independent, removable extension members adapted to be mounted at the distal end of the retractor, or between the blades of a spreadable retractor, after the retractor has been positioned in the patient, such that a significant portion of the extension member extends beyond the distal end of the retractor to preclude or minimize intrusion of tissue into the access area created by the retractor. The extension members may vary in size and shape so that the most appropriate extension member can be chosen to address the intrusion problem, and the extension members may be mounted at various fixed locations, using clips, mechanical interlocking structures or the like.2010-05-06
20100113882SURGICAL ACCESS PORT WITH MULTILAYERED TORTUOUS PATH SEAL - A surgical access device includes a wound protector and an instrument seal. The instrument seal comprises a plurality of resilient membranes each having a plurality of parallel slits. The membranes are stacked relative one another to create a tortuous path preventing insufflatory gases from escaping through the instrument seal.2010-05-06
20100113883SURGICAL ACCESS PORT WITH ADJUSTABLE RING GEOMETRY - A surgical access device has an instrument seal. A wound protector is connectable to the instrument seal. The wound protector comprises a distal ring, a proximal ring, and a resilient sleeve extending between the distal and proximal rings. The diameter of the distal ring is adjustable between a retracted position and an expanded position.2010-05-06
20100113884Surgical Access System and Related Methods - A system for accessing a surgical target site and related methods, involving an initial distraction system for creating an initial distraction corridor, and an assembly capable of distracting from the initial distraction corridor to a secondary distraction corridor and thereafter sequentially receiving a plurality of retractor blades for retracting from the secondary distraction corridor to thereby create an operative corridor to the surgical target site, both of which may be equipped with one or more electrodes for use in detecting the existence of (and optionally the distance and/or direction to) neural structures before, during, and after the establishment of an operative corridor to a surgical target site.2010-05-06
20100113885RETRACTOR ASSEMBLIES FOR SURGERY IN A PATIENT - An assembly for tissue retraction in surgery includes a pair of arm members removably positioned on and movable along an elongate support member. The arm members each include an external housing, a locking member positioned within the external housing and a passageway extending through the external housing and the locking member. The elongate support member extends through the passageways and the locking members are releasably biased into engagement with the elongate support member to allow the arm members to move in opposite directions along the elongate support member and prevent the arm members from moving toward one another. Each arm member further includes a rotatable engagement portion engageable with a respective retractor portion and a locking element releasably biased into engagement with the engagement portion to limit rotation of the engagement portion to a first direction relative to the arm member.2010-05-06
20100113886SURGICAL PORT ASSEMBLY - A surgical port comprising a body and first and second cannula extending from the body and movable with respect to the body via an instrument inserted through the respective cannula. The cannulas can extend distally from the body and can include one or more seals. A port assembly and first and second instruments manipulatable in a crossed configuration are also disclosed.2010-05-06
20100113887PATIENT-BASED PARAMETER GENERATION SYSTEMS FOR MEDICAL INJECTION PROCEDURES - A system includes a parameter generation system to determine parameters of at least one phase of an injection procedure based at least in part upon a type of the injection procedure. The parameter generator system determines the amount of a pharmaceutical that is to be delivered to a patient at least in part on the basis of the concentration of an agent in the pharmaceutical and at least on part on the basis of a function that depends upon and varies with a patient parameter. The patient parameter can, for example, be weight, body mass index, body surface area or cardiac output. The pharmaceutical can, for example, include a contrast enhancing agent for use in an imaging procedure.2010-05-06
20100113888HEART FAILURE DECOMPENSATION DETERMINATION - Heart failure decompensation is detected by sensing at least one physiological signal. Values of at least two different heart failure variables are derived using one or more physiological signals and a threshold for the first heart failure variable is adjusted in response to the value of the second heart failure variable. The value of the first heart failure variable is compared to first threshold for detecting a heart failure condition.2010-05-06
20100113889CARDIAC RISK STRATIFICATION UTILIZING BAROREFLEX SENSITIVITY MEASUREMENT - A monitoring or therapy system may obtain a baroreflex sensitivity (BRS) measurement via an implantable medical device (IMD). The monitoring or therapy system then may generate a risk stratification indicator based on the BRS measurement. In some examples, the IMD generates the risk stratification indicator, while in other examples, an external computing device, such as a programmer, generates the risk stratification indicator. The monitoring or therapy system also may obtain at least one of a heart rate variability (HRV) measurement and a non-sustained ventricular tachycardia (NSVT) indicator via the IMD, and may generate the risk stratification indicator based on the BRS measurement and one or both of the HRV measurement and the NSVT indicator. In some examples, the monitoring or therapy system may generate an instruction, indicator, or alert based on the risk stratification indicator. The indicator may indicate that the patient is a candidate for an implantable therapy device.2010-05-06
20100113890HEART FAILURE PATIENT MANAGEMENT USING AN IMPLANTABLE MONITORING SYSTEM - An implantable medical device system and method provide physiological variable monitoring for use in patient management. A target value for a physiological variable and formulations for computing metrics of the physiological variable are stored. Values of the physiological variable are determined from a sensed physiological signal and are used to compute a selected metric. The metric is compared to the stored target value.2010-05-06
20100113891HEMODIALYSIS PATIENT DATA ACQUISITION, MANAGEMENT AND ANALYSIS SYSTEM - A hemodialysis patient data acquisition and management system resides on a host computer which receives information from one or more non-invasive, optical blood monitors associated with a hemodialysis system. When a patient is undergoing hemodialysis treatment, a sensor assembly monitors the patient's blood flowing through the hemodialysis system and a controller for the blood monitor generates data which includes at least an identification code for the patient undergoing the treatment on the respective system, and non-invasively determined blood data taken at the onset of the scheduled treatment, such as initial Hgb, HCT, and SAT values. A host computer communicates with the one or more optical blood monitors, preferably via a wireless network, and the patient's session commencement data is downloaded to the host computer. The host computer includes a patient database containing historical session commencement data for a plurality of patients, as well as screen displays for displaying historical data for individual patients, such as Hgb trends. The system also preferably provides a predictive algorithm for the patient's Hgb at the patient's next scheduled hemodialysis treatment session. The preferred system also includes software that provides a recommended dose of the anemia management drug for the patient.2010-05-06
20100113892METHOD FOR DETERMINING PERSONALIZED NUTRITION AND DIET USING NUTRIGENOMICS AND PHYSIOLOGICAL DATA - This invention relates generally to providing nutrigenomic information tailored to that of the customer so that the customer can make informed decisions regarding diet, exercise, risks of disease and other health issues that result in a healthier lifestyle and prolonged lifespan. In particular the invention provides systems for research and commercial purposes, particularly for research for improving dietary constituents, personalized nutrition and diets, and of nutrient-gene interactions involved in diseases. The invention further relates to a method for doing business encompassing establishing and running a nutrigenomic research super-market and providing validated nutrient intake data to health care practitioners.2010-05-06
20100113893METHOD FOR MEASURING PHYSIOLOGICAL STRESS - Method for determining physiological stress. One or more physiologic signals in a subject is detected. The one or more physiologic signals are processed to obtain one or more processed signals. The subject's stress level is estimated from the one or more processed signals. The one or more physiological signals may include the electrocardiogram, instantaneous lung volume or other signal reflecting respiratory activity, or the arterial blood pressure or other signal reflecting cardiovascular activity.2010-05-06
20100113894METHODS AND DEVICES FOR MEASURING CORE BODY TEMPERATURE - A core body temperature measurement device includes a plurality of electronic temperature sensors (2010-05-06
20100113895System and method for improving data management between implantable medical devices and external devices - Systems, methods and devices are provided for improving data management between implantable medical devices (IMDs) and external devices for the detection of volume overload and volume depletion conditions. Data acquired by the IMD is periodically communicated to the external device where a volume overload monitoring algorithm is operated to detect whether a volume overload condition is present in the patient by monitoring the acquired data at the external device at a first lower, non-real-time frequency rate. Upon detection of a volume overload condition, the external device issues an instruction to the IMD causing the IMD to initiate a volume depletion condition monitoring algorithm for detecting in real time whether a volume depletion condition is present in the patient.2010-05-06
20100113896DIAGNOSTIC DEVICE WITH DISPLAY MODULE AND LEVERAGED COMPONENT CONNECTIONS - The present invention provides an innovative means for efficient and secure component assembly and for ensuring secure electrical connections in a small diagnostics device where available space for fasteners is limited. In one embodiment, principles of leverage are employed to produce a force at a location where space is available. The force is transferred to a different location of the assembly where it is used to maintain secure connections between components.2010-05-06
20100113897CONTINUOUS ANALYTE MONITORING ASSEMBLY AND METHODS OF USING THE SAME - A continuous analyte monitoring assembly is adapted to assist in determining an analyte level of a fluid. The monitoring assembly includes a housing, electronics, an implantable sensor and a cannula. The housing has a bottom in which the bottom forms a recess. The electronics are located within the housing and assist in determining an analyte level of a fluid sample. The sensor moves from a retracted position to an inserted position using the recess. The cannula assists in placing the implantable sensor.2010-05-06
20100113898APPARATUS AND METHOD OF PROCESSING PLURALITY OF BIOLOGIC SIGNALS - An apparatus for integrally processing a plurality of biologic signals includes a first signal processing module and a second signal processing module. The first processing module generates a signal for operating a sensing module, which includes a plurality of sensor groups which measures the plurality of biologic signals, and which processes a biologic signal provided from the plurality of sensor groups based on a control signal. The second signal processing module authenticates a sensor group from among the plurality of sensor groups, generates the control signal according to a result of the authentication while automatically setting a processing condition, processes the biologic signal provided from the first signal processing module according to the processing condition and outputs a result of processing the biologic signal.2010-05-06
20100113899Alignment System for Optically Sampling a Hand - This invention relates to measurements of material properties by determination of the response of a sample to incident radiation, and more specifically to the measurement of analytes such as glucose or alcohol in human tissue. Some example embodiments of the present invention provide an optical sampling apparatus including an optical subsystem, having a receiver for receiving light expressed from tissue; and an alignment subsystem, adapted to urge a portion of a hand placed in operative relationship with the alignment subsystem into a defined configuration relative to the receiver. In some such example embodiments, the alignment subsystem includes a substrate having a plurality of projections therefrom disposed in a pattern such that the projections urge a portion of a hand placed on the substrate to a defined configuration relative to the receiver. In some such example embodiments, the alignment subsystem includes a substrate having a surface defining a volume approximating the shape of a portion of a hand such that the volume urges a portion of a hand placed therein to a defined configuration relative to the receiver. In some such example embodiments, the alignment subsystem includes a surface having a generally U-shaped cross-section and extending for a distance, wherein the surface is mounted relative to the sampling means such that a finger placed in the U-shaped cross-section of the surface is urged to a defined configuration relative to the receiver. In some such sample embodiments, the alignment subsystem is customized to portion of the hand of a specific individual.2010-05-06
20100113900Multispot Monitoring for Use in Optical Coherence Tomography - Optical coherence tomography (herein “OCT”) based analyte monitoring systems are disclosed. In one aspect, techniques are disclosed that can identify fluid flow in vivo (e.g., blood flow), which can act as a metric for gauging the extent of blood perfusion in tissue. For instance, if OCT is to be used to estimate the level of an analyte (e.g., glucose) in tissue, a measure of the extent of blood flow can potentially indicate the presence of an analyte correlating region, which would be suitable for analyte level estimation with OCT. Another aspect is related to systems and methods for scanning multiple regions. An optical beam is moved across the surface of the tissue in two distinct manners. The first can be a coarse scan, moving the beam to provide distinct scanning positions on the skin. The second can be a fine scan where the beam is applied for more detailed analysis.2010-05-06
20100113901Contact lens integrated with a biosensor for the detection of glucose and other components in tears - The present invention provides contact lens with integrated biosensor for the continuous, non-invasive monitoring of physiological glucose by employing biocompatible nanostructure-laden lens materials. These contact lenses can be worn by diabetics who can colorimetrically see changes in their contact lens color or other fluorescence-based properties, giving an indication of tear and blood glucose levels. This invention for the glucose biosensor based on the new disposal contact lens provides a safe, convenient and non-expensive glucose sensing device. The sensing device disclosed herein provides an efficient and noninvasive solution for monitoring blood glucose.2010-05-06
20100113902Small Bore Magnetic Resonance Imaging Photoplethysmographic Sensor - An efficient, effective, MRI compatible small bore MRI noninvasive photoplethysmographic sensor for animals such as small rodents, namely rats and mice. The photoplethysmographic sensor for animals comprising: a non-magnetic sensor coupling attachable to an animal; fiber optic cable coupled to the sensor coupling and configured to deliver a signal to and receive a signal from the animal tissue adjacent the sensor coupling; an opto-electical converter coupled to the fiber optic cable, the converter including a receiver coupled the fiber optic cable portion configured to receive a signal from the animal tissue and including an emitter coupled to the fiber optic portion configured to deliver a signal to the animal tissue; an electronic coupling extending from the opto-electric converter and configured to be coupled to the emitter and the receiver, wherein the electronic coupling is configured to extend outside of the MRI chamber; and a processor coupled to the electronic coupling.2010-05-06
20100113903PULSE OXIMETER SENSOR WITH PIECE-WISE FUNCTION - A memory in a sensor is used to store multiple coefficients for a physiological parameter. In one embodiment, not only are the sensor's specific calibration coefficients stored in a memory in the sensor for the formula to determine oxygen saturation, but multiple sets of coefficients are stored. The multiple sets apply to different ranges of saturation values to provide a better fit to occur by breaking the R to SpO2 relationship up into different pieces, each described by a different function. The different functions can also be according to different formulas for determining oxygen saturation.2010-05-06
20100113904System And Method For Facilitating Observation Of Monitored Physiologic Data - Present embodiments are directed to a system and method capable of detecting and graphically indicating physiologic patterns in patient data. For example, present embodiments may include a monitoring system that includes a monitor capable of receiving input relating to patient physiological parameters and providing indications or alarms related to oxygen saturation declines and oxygen desaturation patterns associated with sleep apnea. Present embodiments may include methods and systems for mediating between alarms and other indicators associated with oxygen desaturation and ventilatory instability.2010-05-06
20100113905Ultrasound Image Display With Additional Information Using PPG and ECG Signals - An embodiment for displaying an ultrasound image with additional information using a photoplenthysmography (PPG) signal and an electrocardiogram (ECG) signal in an ultrasound system is disclosed. The ultrasound system includes a photoplenthysmography (PPG) signal generating unit and an electrocardiogram (ECG) signal generating unit. The PPF signal generating unit and the ECG signal generating unit generate a PPG signal for the target object and an ECG signal for the target object, respectively. An additional information forming unit forms additional information by using the PPG signal and the ECG signal. A display unit displays ultrasound images of the target object together with the additional information.2010-05-06
20100113906HYBRID BASKET CATHETERS - The invention provides hybrid basket-type intravascular catheter probes designed to optimize blood vessel wall contact or close proximity while traversing tortuous curves. Related diagnostic systems and methods are also provided.2010-05-06
20100113907Tubular sensor for the detection of an analyte - An implantable sensor can be used for determining a concentration of at least one analyte in a medium, particularly in a body tissue and/or a body fluid. The implantable sensor can comprise a flexible, tubular sensor element. This sensor element has a tubular body on which at least two electrode rings are mounted for electrochemical determination of the concentration of the analyte.2010-05-06
20100113908System And Method For Facilitating Observation Of Monitored Physiologic Data - Present embodiments are directed to a system and method capable of detecting and graphically indicating physiologic patterns in patient data. For example, present embodiments may include a monitoring system that includes a monitor capable of receiving input relating to patient physiological parameters and storing historical data related to the parameters. Additionally, the monitoring system may include a screen capable of displaying the historical data corresponding to the patient physiological parameters. Further, the monitoring system may include a pattern detection feature capable of analyzing the historical data to detect a physiologic pattern in a segment of the historical data and capable of initiating a graphical indication of the segment on the screen when the physiologic pattern is present in the segment.2010-05-06
20100113909System And Method For Facilitating Observation Of Monitored Physiologic Data - Present embodiments are directed to a system and method capable of detecting and graphically indicating physiologic patterns in patient data. For example, present embodiments may include a monitoring system that includes a monitor capable of receiving input relating to patient physiological parameters and storing historical data related to the parameters. Additionally, the monitoring system may include a screen capable of displaying the historical data corresponding to the patient physiological parameters. Further, the monitoring system may include a pattern detection feature capable of analyzing the historical data to detect a physiologic pattern in a segment of the historical data and capable of initiating a graphical indication of the segment on the screen when the physiologic pattern is present in the segment.2010-05-06
20100113910SENSOR ARRANGEMENT AND METHOD FOR MONITORING PHYSIOLOGICAL PARAMETERS - The invention refers to a sensor arrangement with at least one sensor and a method for monitoring physiological aparameters of a person, a textile fabric and a use of a textile fabric. An sensor arrangement is described that is suited to improve signal quality and suppress noise, for instance in remote capacitive sensing of body parameters. To achieve this, certain textile fabrics are used, preferably integrated into textile used in a bed, e.g. the blanket, the bed cover, or the mattress. These textile fabrics allow for a suppression of electromagnetic interference from external sources and can be arranged to avoid charge build-up during measurements, in particular those caused by movements of the person.2010-05-06
20100113911System for Delivering Conformal Radiation Therapy While Simultaneously Imaging Soft Tissue - A device and a process for performing high temporal- and spatial-resolution MR imaging of the anatomy of a patient during intensity modulated radiation therapy (IMRT) to directly measure and control the highly conformal ionizing radiation dose delivered to the patient for the treatment of diseases caused by proliferative tissue disorders. This invention combines the technologies of open MRI, multileaf-collimator or compensating filter-based IMRT delivery, and cobalt teletherapy into a single co-registered and gantry mounted system.2010-05-06
20100113912SMALL DIAMETER MRI MARKER AND RELATED METHOD - A marker comprising a hollow body filled with a magnetic resonance imaging medium is used to mark specific surface areas of concern or sources of pain on a patient's skin prior to commencing MRI imaging procedures. The hollow body is sized such that the marker appears on less than five MRI slice images, and preferably not more than two MRI slice images, thereby enabling a physician or technician to precisely locate and assess a patient's condition based on the location of the marker in the MRI images.2010-05-06
20100113913MAGNETIC RESONANCE IMAGING APPARATUS, BED DEVICE FOR MAGNETIC RESONANCE IMAGING APPARATUS AND TABLE TOP OF BED DEVICE FOR MAGNETIC RESONANCE IMAGING APPARATUS - A number of C-FRP molded material sections that are elongated and made from a carbon fiber reinforced plastic are placed parallel to each other. The C-FRP molded material sections are insulated from each other by honeycomb material sections that are made from an insulating and nonmagnetic material. The C-FRP molded material sections and the honeycomb material sections are maintained by a glass fiber layer into a sheet plate shape.2010-05-06
20100113914BLOOD FLOW DYNAMIC ANALYSIS APPARATUS AND METHOD, AND MAGNETIC RESONANCE IMAGING SYSTEM - A blood flow dynamic analysis apparatus acquires data from a plurality of regions lying in slices set to a subject with a contrast agent injected therein and analyzes blood flow dynamics of the subject, based on the data. The apparatus includes a contrast agent concentration profile generation device for generating profiles each indicative of a temporal change in the concentration of the contrast agent for every said region lying in the slices, a characteristic amount calculation device for calculating the concentrations of the contrast agent in the regions after a bolus of contrast agent has passed through the regions, from the profiles, a histogram generation device for generating a histogram containing the concentrations of the contrast agent in the regions after the bolus of contrast agent has passed though the regions, a region determination device for determining a region in which each vein exists, from the regions, based on the histogram, and a function calculation device for calculating a venous output function, based on a temporal change in the concentration of the contrast agent in the region in which the vein exists.2010-05-06
20100113915ORTHOGONALLY POSITIONED TAGGING IMAGING METHOD FOR ARTERIAL LABELING WITH FAIR - Methods, devices, and systems for creating an MRI image using an orthogonally positioned tagging imaging method for arterial labeling with FAIR. Embodiments of the present methods for creating an MRI image may include positioning a perfusion imaging plane that corresponds to an image target area of an imaging object, and causing an MRI image to be generated that corresponds to a representation of the image target area at the perfusion imaging plane. The perfusion imaging plane may be orthogonal to a direction of inflow from immediately proximal arteries of the image target area.2010-05-06
20100113916Systems and Methods for Endotracheal Tube Positioning - Certain embodiments of the presently described technology provide methods and systems for positioning of an endotracheal tube. Certain embodiments provide an endotracheal tube system including an endotracheal tube and a removable positioning member. The endotracheal tube is sized and adapted for providing airway maintenance during an endotracheal procedure. The removable positioning member is sized and adapted to be insertable into and removable from the endotracheal tube. The removable positioning member includes a positioning element located proximal to the distal end of the removable positioning member. The positioning element provides an indication of position when at least a portion of the endotracheal tube is inside of a patient.2010-05-06
20100113917SYSTEM AND METHOD FOR TRACKING OBJECT - In one embodiment, a position transponder for operation inside the body of a subject is provided. The transponder comprises a variable resistor and a magneto resistor coupled to the variable resistor. The variable resistor comprises an electronic device having a gate terminal, a source terminal and a drain terminal and a sensor coil coupled to the electronic device between the gate terminal and the source terminal.2010-05-06
20100113918SYSTEM AND METHOD FOR TRACKING OBJECT - In one embodiment, a position transponder for operation inside the body of a subject is provided. The transponder comprises a sensor coil and a magneto resistor coupled in series to the sensor coil.2010-05-06
20100113919Catheter arangement for insertion into a blood vessel for minimally invasive intervention - A catheter arrangement for insertion into a blood vessel is proposed. The catheter arrangement has a catheter with a proximal catheter tip, in which an intervention tool is guided to remove a blood clot from the blood vessel. The intervention tool has an element for trapping a blood clot, in particular a spiral, in the region of its tip. With a view to minimizing x-ray radiation during the treatment and safe guidance of the intervention tool a position identification element is disposed in the region of the catheter tip.2010-05-06
20100113920METHODS FOR DEFINING AND MARKING TISSUE - In order to later identify the location of a biopsy or surgery, various means and methods for permanently and non-surgically marking selected tissue in the human body are used. Later visualization of the markers is readily accomplished using state-of-the-art imaging systems.2010-05-06
20100113921Systems and Methods for Object Surface Estimation - Systems and methods are provided that provide for surface estimation of an object. In particular, the surface estimation can be determined with little or no a priori information regarding the position or topography of the object within a given volume. In select embodiments, the systems and methods can be used for microwave imaging, and particularly for estimating breast surfaces during the imaging process.2010-05-06
20100113922Methods and devices for removing tissue from a patient and placing a marker in the patient - The device is used to remove tissue from a patient and to also place a marker in the patient. The device has an opening through which tissue enters the device. The tissue, which enters the opening is cut and the tissue is removed. The device may be used a number of times to remove a number of tissue masses. The device also includes a marker, which the user may release in the patient at the desired time.2010-05-06
20100113923MATING MECHANISM FOR A PRESSURIZING UNIT AND CORRESPONDING SLEEVE IN A MEDICAL FLUID INJECTION DEVICE - In general, this disclosure relates to techniques for providing a mating mechanism between at least one pressurizing unit and at least one corresponding sleeve in a powered medical fluid injection device. An example powered medical fluid injection device includes a sleeve and an injector head coupled to the sleeve. The sleeve has a notch with a predefined shape and size. The sleeve is configured to receive a pressurizing unit (such as a syringe) having an external tab with a predefined shape and size that are substantially identical to the predefined shape and size of the notch in the sleeve, such that the tab mates with the notch when the sleeve receives the pressurizing unit. The injector head is configured to inject a quantity of a medical fluid from the pressurizing unit during operation.2010-05-06
20100113924AUTOMATICALLY SUPPLYING A PRESSURIZING UNIT OF A MEDICAL INJECTION DEVICE WITH FLUID - In general, this disclosure relates to techniques for automatically supplying a pressurizing unit (e.g., syringe) that is used with a powered medical fluid injection device with fluid. An example method performed by the medical fluid injection device includes obtaining operational state information of the medical fluid injection device, wherein the operational state information includes information other than a fluid delivery amount for a subsequent injection procedure. The example method further includes using the operational state information to determine whether the powered medical fluid injection device permits a fluid replenishment operation for the pressurizing unit. If the fluid replenishment operation is permitted, the method further includes automatically supplying the pressurizing unit with an amount of medical fluid. If the device includes multiple pressurizing units, the device may initiate an automatic fluid replenishment procedure for one or more of the pressurizing units during operation.2010-05-06
Website © 2025 Advameg, Inc.